Cargando…

Bioprinting Vasculature: Materials, Cells and Emergent Techniques

Despite the great advances that the tissue engineering field has experienced over the last two decades, the amount of in vitro engineered tissues that have reached a stage of clinical trial is limited. While many challenges are still to be overcome, the lack of vascularization represents a major mil...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomasina, Clarissa, Bodet, Tristan, Mota, Carlos, Moroni, Lorenzo, Camarero-Espinosa, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747573/
https://www.ncbi.nlm.nih.gov/pubmed/31450791
http://dx.doi.org/10.3390/ma12172701
_version_ 1783451930058555392
author Tomasina, Clarissa
Bodet, Tristan
Mota, Carlos
Moroni, Lorenzo
Camarero-Espinosa, Sandra
author_facet Tomasina, Clarissa
Bodet, Tristan
Mota, Carlos
Moroni, Lorenzo
Camarero-Espinosa, Sandra
author_sort Tomasina, Clarissa
collection PubMed
description Despite the great advances that the tissue engineering field has experienced over the last two decades, the amount of in vitro engineered tissues that have reached a stage of clinical trial is limited. While many challenges are still to be overcome, the lack of vascularization represents a major milestone if tissues bigger than approximately 200 µm are to be transplanted. Cell survival and homeostasis is to a large extent conditioned by the oxygen and nutrient transport (as well as waste removal) by blood vessels on their proximity and spontaneous vascularization in vivo is a relatively slow process, leading all together to necrosis of implanted tissues. Thus, in vitro vascularization appears to be a requirement for the advancement of the field. One of the main approaches to this end is the formation of vascular templates that will develop in vitro together with the targeted engineered tissue. Bioprinting, a fast and reliable method for the deposition of cells and materials on a precise manner, appears as an excellent fabrication technique. In this review, we provide a comprehensive background to the fields of vascularization and bioprinting, providing details on the current strategies, cell sources, materials and outcomes of these studies.
format Online
Article
Text
id pubmed-6747573
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67475732019-09-27 Bioprinting Vasculature: Materials, Cells and Emergent Techniques Tomasina, Clarissa Bodet, Tristan Mota, Carlos Moroni, Lorenzo Camarero-Espinosa, Sandra Materials (Basel) Review Despite the great advances that the tissue engineering field has experienced over the last two decades, the amount of in vitro engineered tissues that have reached a stage of clinical trial is limited. While many challenges are still to be overcome, the lack of vascularization represents a major milestone if tissues bigger than approximately 200 µm are to be transplanted. Cell survival and homeostasis is to a large extent conditioned by the oxygen and nutrient transport (as well as waste removal) by blood vessels on their proximity and spontaneous vascularization in vivo is a relatively slow process, leading all together to necrosis of implanted tissues. Thus, in vitro vascularization appears to be a requirement for the advancement of the field. One of the main approaches to this end is the formation of vascular templates that will develop in vitro together with the targeted engineered tissue. Bioprinting, a fast and reliable method for the deposition of cells and materials on a precise manner, appears as an excellent fabrication technique. In this review, we provide a comprehensive background to the fields of vascularization and bioprinting, providing details on the current strategies, cell sources, materials and outcomes of these studies. MDPI 2019-08-23 /pmc/articles/PMC6747573/ /pubmed/31450791 http://dx.doi.org/10.3390/ma12172701 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tomasina, Clarissa
Bodet, Tristan
Mota, Carlos
Moroni, Lorenzo
Camarero-Espinosa, Sandra
Bioprinting Vasculature: Materials, Cells and Emergent Techniques
title Bioprinting Vasculature: Materials, Cells and Emergent Techniques
title_full Bioprinting Vasculature: Materials, Cells and Emergent Techniques
title_fullStr Bioprinting Vasculature: Materials, Cells and Emergent Techniques
title_full_unstemmed Bioprinting Vasculature: Materials, Cells and Emergent Techniques
title_short Bioprinting Vasculature: Materials, Cells and Emergent Techniques
title_sort bioprinting vasculature: materials, cells and emergent techniques
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747573/
https://www.ncbi.nlm.nih.gov/pubmed/31450791
http://dx.doi.org/10.3390/ma12172701
work_keys_str_mv AT tomasinaclarissa bioprintingvasculaturematerialscellsandemergenttechniques
AT bodettristan bioprintingvasculaturematerialscellsandemergenttechniques
AT motacarlos bioprintingvasculaturematerialscellsandemergenttechniques
AT moronilorenzo bioprintingvasculaturematerialscellsandemergenttechniques
AT camareroespinosasandra bioprintingvasculaturematerialscellsandemergenttechniques